SS  Vol.3 No.10 , October 2012
Comparison of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Magnetic Resonance Cholangiopancreatography (MRCP) in Bile Duct Imaging
Purpose: The aim of this study was to compare magnetic resonance cholangiopancreatography (MRCP) with endoscopic retrograde cholangiopancreatography (ERCP) in diagnosing bile duct pathologies. Materials and Methods: We documented the data of 171 patients with both ERCP and MRCP between January 2009 and December 2010 at the Konya Education and Research Hospital. Results: Of the 171 patients, 100 (58.5%) were female and 71 (41.5%) were male. The median age was 63 (55 to 89). ERCP was used to diagnose bile duct stones in 102 (59%) patients, bile duct tumour in 14 (8%) patients, hydatic cysts opening up to the bile duct in 4 (2%) patients and bile duct stenosis in 3 (1.8%) patients. For the detection of bile duct stones, MRCP had a sensitivity of 92%, a specificity of 74% and a diagnostic accuracy of 83%. For bile duct tumours, MRCP had a sensitivity of 85%, a specificity of 98% and a diagnostic accuracy rate of 92%. Conclusion: In our centre, the results of MRCP and ERCP were similar for the last two years. However, MRCP was superior with respect to diagnosis as it was cheaper and non-invasive. Thus, ERCP should be preferred for therapeutic processes.

Cite this paper
M. Eryılmaz, Ö. Karahan, İ. Tolu, A. Okuş, S. Ay, B. Sevinç and A. Halıcı, "Comparison of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Magnetic Resonance Cholangiopancreatography (MRCP) in Bile Duct Imaging," Surgical Science, Vol. 3 No. 10, 2012, pp. 489-493. doi: 10.4236/ss.2012.310097.

[1]   E. Eludokuz, E. Tankurt, H. Akbaylar, E. Igci, O. Dicle, I. Simsek, et al., “The Sensitivity of Ultrasonography in Cases Choledocholithiasis Diagnosed with ERCP,” Turkiye Klinikleri Journal of Gastroenterohepatology, Vol. 7, 1996, pp. 108-110.

[2]   P. D. Prabhakar, A. M. Prabhakar, H. B. Prabahakar and D. Sahani, “Magnetic Resonance Cholangiopancreatography of Benign Disorders of the Biliary System,” Magnetic Resonance Imaging Clinics of North America, Vol. 18, No. 3, 2010, pp. 497-514. doi:10.1016/j.mric.2010.08.007

[3]   G. Ersoz, “Endoscopic Retrograde Cholangiopancreatography in Bile Duct Disorders,” Turkiye Klinikleri Journal of Medical Sciences, Vol. 3, 2007, pp. 12-16.

[4]   H. Senturk, B. Canbakan and E. Ozden, “ERCP: Indications and Risks,” Series of Clinical Approach in Gastroenterology, Vol. 30, 2004, pp. 101-109.

[5]   F. Maccioni, M. Martinelli, N. Al Ansari, A. Kagarmanova, et al., “Magnetic Resonance Cholangiography: Past, Present and Future: A Review,” European Review for Medical and Pharmacological Sciences, Vol. 14, No. 8, 2010, pp. 721-725.

[6]   E. C. Kaltenthaler, S. J. Walters, J. Chilcott, A. Blakeborough, Y. B. Vergel and S. Thomas, “MRCP Compared to Diagnostic ERCP for Diagnosis When Biliary Obstruction Is Suspected: A Systematic Review,” BMC Medical Imaging, Vol. 6, 2006, pp. 9-24. doi:10.1186/1471-2342-6-9

[7]   M. G. Scaffidi, C. Luigiano, P. Consolo, R. Pellicano, G. Giacobbe, M. Gaeta, et al., Magnetic Resonance Cholangiopancreatography versus Endoscopic Retrograde Cholangiopancreatography in the Diagnosis of Common Bile Duct Stones: A Prospective Comparative Study,” Minerva Medica, Vol. 100, No. 5, 2009, pp. 341-348.

[8]   E. L. Hanninen, H. Amthauer, N. Hosten, J. Ricke, M. Bohmig, J. Langrehr, et al., “Prospective Evaluation of Pancreatic Tumours: Accuracy of MR Imaging with MR Cholangiopancreatography and MR Angiography,” Radiology, Vol. 224, No. 1, 2002, pp. 34-41. doi:10.1148/radiol.2241010798

[9]   P. Angulo, D. H. Pearce, C. D. Johnson, J. J. Henry, N. F. Larusso, B. T. Petersen, et al., “Magnetic Resonance Cholangiopancreatography in Patients with Biliary Disease: Its Role in Primary Sclerosing Cholangitis,” Journal of Hepatology, Vol. 33, No. 4, 2000, pp. 520-527. doi:10.1016/S0168-8278(00)80002-1

[10]   G. Galati, A. V. Sterpetti, M. Caputo, M. Adduci, G. Lucandri, S. Brozzetti, et al., “Endoscopic Retrograde Cholangiography for Intrabiliary Rupture of Hydatic Cyst,” The American Journal of Surgery, Vol. 191, No. 2, 2006, pp. 206-210. doi:10.1016/j.amjsurg.2005.09.014

[11]   M. M. Calvo, L. Bujanda, A. Calderon, J. L. Cabriada, A. Bernal, V. Orive, et al., “Role of Magnetic Resonance Cholangiopancreatography in Patients with Suspected Choledocholithiasis,” Mayo Clinic Proceedings, Vol. 77, No. 5, 2002, pp. 422-428. doi:10.1016/S0025-6196(11)62210-6

[12]   E. Kaltenthaler, Y. B. Vergel, J. Chilcott, S. Thomas, T. Blakeborough, S. J. Waters, et al., “A Systematic Review and Economic Evaluation of Magnetic Resonance Cholangiopancreatography Compared with Diagnostic Endoscopic Retrograde Cholangiopancreatography,” Health Technology Assessment, Vol. 8, No. 10, 2004, pp. 1-89.

[13]   R. Schofl, “Diagnostic Endoscopic Retrograde Cholan- giopancreatography,” Endoscopy, Vol. 33, No. 2, 2001, pp. 147-157. doi:10.1055/s-2001-11667

[14]   M. L. Freeman, D. B. Nelson, S. Sherman, G. B. Haber, M. E. Herman, P. J. Dorsher, et al., “Complications of Endoscopic Biliary Sphincterotomy,” The New England Journal of Medicine, Vol. 335, No. 13, 1996, pp. 909-919. doi:10.1056/NEJM199609263351301

[15]   T. Obana, N. Fujita, Y. Noda, G. Kobayashi, K. Ito, J. Horaguchi, et al., “Efficacy and Safety of Therapeutic ERCP for the Elderly with Choledocholithiasis: Comparison with Younger Patients,” Internal Medicine, Vol. 49, No. 18, 2010, pp. 1935-1941. doi:10.2169/internalmedicine.49.3660

[16]   K. Hekimoglu, Y. Ustundag, A. Dusak, Z. Erdem, B. Karademir, S. Aydemir, et al., “MRCP vs ERCP in the Evaluation of Biliary Pathologies: Review of Current Literature,” Journal of Digestive Diseases, Vol. 9, No. 3, 2008, pp. 162-169. doi:10.1111/j.1751-2980.2008.00339.x